STAT

Are we spending too much on the dying? New research challenges this widely held view

Death is unpredictable, even in people who are very sick, say the authors of a new study that pushes back against the widely held view that much of Medicare spending…
Source: John Moore/Getty Images

Maybe you have heard the refrain before: The U.S. spends too much money on the dying. Every year, 5 percent of Medicare beneficiaries die, but one-quarter of spending occurs in the last year of life. Side by side, these stats have fed a widely held belief that, in an exorbitantly expensive health care system, much of end-of-life care goes to waste.

A , published in the journal Science, pushes back on this notion. The researchers, a team of three economists and one physician, used machine learning

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About The Purdue Bankruptcy Ruling, A Merck Rejection, And More
In today's Pharmalittle roundup, we're reading about the Purdue bankruptcy ruling, a Merck rejection, and more.
STAT1 min read
STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Alzheimer’s Drug, An EU Contract For Bird Flu Vaccine, And More
Advisers to the FDA voted unanimously to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly.

Related Books & Audiobooks